Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Phase III
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase III
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Phase III
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Phase III
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Clinical
Phase III
Phase III
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase III
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
Biospace News
-
January 11, 2021
Phase III
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration – FirstWord Pharma
Phase III
Zydus Cadila submits Phase I/II clinical trial data of ZyCoV-D, seeks nod to start Phase III Clinical Trials – FirstWord Pharma
Phase III
Global Roundup: EU Approves ViiV’s HIV-1 Drug and More
Phase III
Rakuten Medical Enrolls First Patient in the U.S. Clinical Trial for its Lead Product, ASP-1929 in Combination with Anti-PD1 Therapy, for Head and Neck...
Phase III
High-Dose Quadrivalent Influenza Vaccine Shows Favourable Phase 2 Trial Results in...
Firstwordpharma News
-
October 31, 2020
0
Phase III
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases – FirstWord...
Firstwordpharma News
-
October 31, 2020
0
Phase III
Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update...
Globenewswire News
-
October 29, 2020
0
Phase III
Parliament to allow COVID-19 vaccines to be developed more quickly –...
Firstwordpharma News
-
July 10, 2020
0
Phase III
AMRYT PHARMA PLC: Posting of Annual Report and Notice of Agm...
Globenewswire News
-
June 30, 2020
0
1
2
3
...
40
Page 1 of 40
- Advertisement -
MOST POPULAR
Lupus Therapeutics Partners with Takeda on Phase 1 Trial
March 1, 2019
Inflazome Announces Acquisition by Roche
September 21, 2020
Not-for-Profit Generic Drug Company Civica Rx Inks 1st Supplier Deal with...
May 15, 2019
Breast cancer patients to have further NICE-approved drug combination option on...
January 16, 2020
Load more
HOT NEWS
Ophthalmology
ReNeuron Announces Retinal Clinical Trial Progresses to Next Stage
Approval
Chugai Obtains Approval for Additional Indication of Rozlytrek for ROS1 Fusion-Positive...
Phase II
Tolero Pharmaceuticals Announces First Patient Dosed in Phase 2 Zella 202...
Infectious diseases
DH to extend Free Measles Vaccination Mop-up Programme to adult Hong...
